USPTO Examiner DANIEL ANTARIUS S - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18984934HOLD ASSISTANCE DEVICE FOR USE WITH A MEDICAMENT DELIVERY DEVICEDecember 2024August 2025Allow820NoNo
18625053GUIDEWIRE PLACEMENT DEVICEApril 2024October 2025Allow1940YesNo
18545602SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESDecember 2023March 2025Allow1520NoNo
18514304INTRODUCER SHEATHNovember 2023August 2024Allow910NoNo
18374824CATHETER WITH TEXTURED SURFACESeptember 2023October 2024Allow1310NoNo
18457394DRUG DELIVERY DEVICE WITH NEEDLE ACTUATION MECHANISMAugust 2023March 2025Allow1920YesNo
18348954METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASEJuly 2023June 2025Abandon2401NoNo
18210797SYSTEMS AND METHODS FOR ROBOTIC INFECTION TREATMENT OF A PROSTHESISJune 2023July 2025Abandon2510YesNo
18144360ROTATIONALLY BIASED INSERTION MECHANISM FOR A DRUG DELIVERY PUMPMay 2023September 2024Allow1630NoNo
18138599INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKApril 2023September 2024Allow1710NoNo
18191400INTRAVASCULAR DELIVERY SYSTEM AND METHOD FOR PERCUTANEOUS CORONARY INTERVENTIONMarch 2023September 2024Allow1810NoNo
18113572INJECTION DEVICEFebruary 2023January 2025Abandon2320NoNo
18112910Predictive Biological HomeostasisFebruary 2023February 2026Allow3610NoNo
18172200MEDICATION FLUID INFUSION SET COMPONENT WITH INTEGRATED PHYSIOLOGICAL ANALYTE SENSOR, AND CORRESPONDING FLUID INFUSION DEVICEFebruary 2023October 2025Allow3250YesNo
18009897Device for Controlled Injection Across a Variety of Material PropertiesDecember 2022May 2025Allow2930YesNo
18050075INTRODUCER SHEATHOctober 2022August 2023Allow1020YesNo
17919831Reversible ring for male urethral compressionOctober 2022February 2026Abandon4010NoNo
17967482METHOD OF SEALING A SYRINGE BARRELOctober 2022January 2025Allow2720NoYes
17938811GUIDE CATHETER EXTENSION SYSTEM WITH A DELIVERY MICRO-CATHETER CONFIGURED TO FACILITATE PERCUTANEOUS CORONARY INTERVENTIONOctober 2022November 2024Allow2530NoNo
17953662MEDICAMENT INJECTION DEVICESeptember 2022May 2025Allow3150YesNo
17898469NEEDLE ARRAY DEVICEAugust 2022December 2023Abandon1510NoNo
17892399Variable Fluid Flow Rate Control DeviceAugust 2022April 2024Abandon2020NoNo
17881183DELIVERY DEVICE FOR HEMOSTATIC COMPOSITIONSAugust 2022December 2023Abandon1710NoNo
17881476DENTAL ANESTHETIC BUFFERING SYSTEMAugust 2022October 2025Allow3810NoNo
17867098PRE-FILLED PLASTIC SYRINGE CONTAINING A VEGF ANTAGONISTJuly 2022May 2025Abandon3440YesNo
17737512Insufflation Tube for Laparoscopy with Heating Element, Humidifying Agent and Device for Determining the Moisture ContentMay 2022December 2025Abandon4310NoNo
17718587INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKApril 2022April 2023Allow1210NoNo
17635329METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL CONDITIONS BEFORE, DURING, AND/OR AFTER ELECTROMAGNETIC RADIATION TREATMENTFebruary 2022October 2025Abandon4410NoNo
17579011HOLLOW NEEDLE AND PIVOTABLE HUB SYSTEMJanuary 2022May 2024Allow2830NoNo
17617378IN-LINE MEDICATION CRUSHER FOR FEEDING TUBESDecember 2021October 2025Abandon4710NoNo
17530178MEDICAL DEVICE WITH OVERMOLDED ADHESIVE PATCH AND METHOD FOR MAKING SAMENovember 2021December 2025Allow4840NoNo
17611948ADAPTIVE PRIMARY PACKAGING FOR THERAPEUTIC SOLUTIONSNovember 2021April 2025Abandon4010NoNo
17609832LIQUID MEDICINE SELF-INJECTION SYSTEMNovember 2021January 2026Abandon5030NoNo
17609648Multilumen Body for a Medical DeviceNovember 2021May 2025Abandon4210NoNo
17521059CATHETER INSERTION DEVICENovember 2021October 2025Allow4720NoNo
17500763HANDHELD STEERING DEVICES FOR INTRA VASCULAR DEVICES AND ASSOCIATED SYSTEMS AND METHODSOctober 2021September 2025Abandon4810NoNo
17471755WOUND DRESSINGS AND SYSTEMS FOR EFFLUENT MANAGEMENT OF TOPICAL WOUND THERAPY AND RELATED METHODSSeptember 2021July 2024Allow3420NoNo
17461628MEDICAL DEVICE STABILIZATION SYSTEMAugust 2021May 2025Abandon4440YesNo
17401573MEDICAMENT DELIVERY DEVICEAugust 2021November 2024Allow3930YesNo
17388119Microminiature EM Coil Sensor Pull Ring For CatheterJuly 2021September 2025Abandon5021NoNo
17380138INSERTION DEVICE AND ENDOSCOPEJuly 2021August 2025Abandon4920YesNo
17337159NEEDLE COVER RETENTIONJune 2021February 2025Allow4450YesNo
17279024ASSISTING DEVICE FOR LIQUID DRUG PERMEATION APPARATUS AND LIQUID DRUG PERMEATION SYSTEMMarch 2021January 2025Abandon4620YesNo
17207463PEDIATRIC CATHETER SYSTEM AND RELATED DEVICES AND METHODSMarch 2021September 2023Allow3020YesNo
17201349ADDITIONAL FUNCTION OF A SAFETY DEVICE FOR INJECTION DEVICESMarch 2021September 2023Allow3020YesNo
17189462ELONGATE INSTRUMENT AND ELONGATE INSTRUMENT GUARD MEMBER COMPATIBILITYMarch 2021December 2024Abandon4521NoNo
17268747HEATED SURGICAL CANNULA FOR PROVIDING GASES TO A PATIENTFebruary 2021September 2025Abandon5541NoNo
17268417NEEDLE ASSEMBLY AND DRUG INJECTION DEVICE COMPRISING SAMEFebruary 2021December 2024Abandon4620NoNo
17141585INFUSING DEVICES, SYSTEMS AND METHODSJanuary 2021March 2026Abandon6051NoNo
16973976Device for Administering a Medicinal Liquid by InjectionDecember 2020November 2024Allow4740NoNo
16973467A PUMP ARRANGEMENT, CONFIGURED TO BE USED WITH A DOUBLE BREAST PUMP DEVICEDecember 2020April 2024Allow4000NoNo
17114788CATHETER WITH TEXTURED SURFACEDecember 2020June 2023Allow3010NoNo
16972749ELECTRIC BREAST PUMP, METHOD OF CONTROLLING ELECTRIC BREAST PUMP, AND CONTROL PROGRAM FOR ELECTRIC BREAST PUMPDecember 2020August 2025Allow5630NoNo
17109600SINGLE-SITE INSERTION OF MULTIPLE MEDICAL DEVICESDecember 2020June 2023Allow3120YesNo
17109082DRUG INFUSION SETDecember 2020December 2023Abandon3740NoNo
17057728DRUG DELIVERY DEVICE WITH NEEDLE ACTUATION MECHANISMNovember 2020April 2023Allow2900NoNo
16951893ROTATIONALLY BIASED INSERTION MECHANISM FOR A DRUG DELIVERY PUMPNovember 2020January 2023Allow2660YesNo
16951819INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKNovember 2020January 2023Allow2610YesNo
17055171SYSTEMS AND METHODS FOR DELIVERING A SUBSTANCE TO A LIVING BEINGNovember 2020February 2026Abandon6080YesNo
17093004Medical and Dental Safety SyringeNovember 2020August 2022Abandon2110NoNo
17093136SYSTEMS AND METHODS FOR ANCHORING MEDICAL DEVICESNovember 2020October 2023Allow3510NoNo
17085963MONITORING OF PHYSIOLOGICAL PARAMETERS WITH IMPEDANCE MEASUREMENTOctober 2020November 2025Abandon6060YesNo
17062426AMBULATORY MEDICAMENT DEVICE WITH AUTOMATIC RESUMPTION OF MEDICAMENT DELIVERYOctober 2020December 2021Abandon1520YesNo
16948638REFILL AND DOSAGE MANAGEMENT DEVICES AND ASSOCIATED SYSTEMS AND METHODS FOR USE WITH COMPUTERIZED ORAL PRESCRIPTION ADMINISTRATION DEVICESSeptember 2020December 2024Allow5160YesNo
16982684INJECTION DEVICESeptember 2020October 2025Allow6030NoNo
16981994MEDICAMENT CONTAINER HOLDERSeptember 2020December 2024Allow5130NoNo
17017835ELASTOMERIC STRAIN RELIEF LAYERING FOR CATHETERSSeptember 2020November 2024Allow5030YesNo
17003278CHEMICAL FLUID INJECTION DEVICEAugust 2020December 2024Abandon5240NoNo
17001553NEEDLE ARRAY DEVICEAugust 2020December 2024Abandon5250YesNo
17000154SEALS AND REINFORCEMENT FOR IRRIGATED ELECTROPHYSIOLOGY BALLOON CATHETER WITH FLEXIBLE-CIRCUIT ELECTRODESAugust 2020January 2026Abandon6050YesNo
16970722SYRINGE ROLLING APPARATUS AND METHODAugust 2020September 2025Allow6031NoNo
16989293CATHETER SYSTEM WITH EXTENDABLE EXTENSION TUBEAugust 2020February 2023Allow3030YesNo
16963927APPARATUS AND METHOD FOR INJECTING MATERIAL INTO ORGANIC TISSUEJuly 2020September 2024Allow5040NoNo
16894334CLOSED SYSTEM CATHETERJune 2020April 2025Allow5820YesYes
16892082MEDICATION FLUID INFUSION SET COMPONENT WITH INTEGRATED PHYSIOLOGICAL ANALYTE SENSOR, AND CORRESPONDING FLUID INFUSION DEVICEJune 2020November 2022Allow3000NoNo
16884832VERY HIGH VOLUME USER FILLED DRUG DELIVERY DEVICEMay 2020September 2021Allow1610NoNo
16879589SYRINGE SUITABLE FOR HYDROGEN PEROXIDE SOLUTION AND KIT THEREOFMay 2020November 2021Abandon1830YesNo
16762189METHOD AND DEVICE FOR THE NEEDLE-FREE INJECTING OF FLUID INTO A SUBSTRATE, AND FLUID CONTAINER FOR USE IN THE METHOD AND THE DEVICEMay 2020May 2023Abandon3610NoNo
16762198METHOD AND DEVICE FOR THE NEEDLE-FREE INJECTING OF FLUID INTO A SUBSTRATEMay 2020August 2024Allow5140YesNo
16759274INJECTION DEVICEApril 2020April 2023Allow3530YesNo
16830828CATHETER PORTMarch 2020June 2023Abandon3830YesNo
16817835FLUID COLLECTORMarch 2020June 2021Allow1500NoNo
16793120INTRAVASCULAR DELIVERY SYSTEM AND METHOD FOR PERCUTANEOUS CORONARY INTERVENTIONFebruary 2020February 2023Allow3630YesNo
16752075DEVICE AND METHOD FOR MAKING ASEPTIC CONNECTIONSJanuary 2020July 2025Allow6090YesYes
16725704INTRODUCER NEEDLE WITH NOTCHES FOR IMPROVED FLASHBACKDecember 2019January 2022Allow2510NoNo
16708075TUBING MARKERSDecember 2019June 2023Abandon4340NoNo
16613703MEDICAL DEVICE WITH RESILIENTLY RETRACTING SAFETY NEEDLENovember 2019November 2020Allow1210YesNo
16682849SAFETY DEVICE FOR RETRACTION OF A NEEDLE AND GUIDEWIRE FOR MEDICAL PROCEDURES AND METHOD OF USENovember 2019March 2022Allow2811NoNo
16594323TRACHEOSTOMY TUBE HOLDER ATTACHMENTOctober 2019June 2023Abandon4420YesNo
16572384SYRINGE CONTROL ASSEMBLYSeptember 2019May 2025Allow6060NoNo
16558871CATHETER PRIMING DEVICES, SYSTEMS AND METHODSSeptember 2019March 2023Allow4211YesNo
16539032HOSE CADDYAugust 2019April 2024Abandon5630NoNo
16530167CATHETER DELIVERY DEVICEAugust 2019September 2021Allow2610YesNo
16502255Using Alternating Electric Fields to Increase Cell Membrane PermeabilityJuly 2019January 2026Abandon6060NoNo
16439993MANIFOLDS, SYSTEMS, AND METHODS FOR ADMINISTERING REDUCED PRESSURE TO A SUBCUTANEOUS TISSUE SITEJune 2019February 2023Abandon4401NoNo
16343585WARMING DEVICE AND INFUSION SYSTEMApril 2019November 2022Allow4321YesNo
16376894SYSTEMS AND METHODS FOR TOPICAL APPLICATION OF MOLECULAR HYDROGENApril 2019October 2023Allow5431NoNo
16338797PATIENT TRAINING DEVICE FOR USE WITH A SAFETY SYRINGE INJECTORApril 2019November 2022Allow4310NoNo
16366724ASSEMBLY FOR SYRINGE, PREFILLED SYRINGE, SEAL CAP FOR PIERCING NEEDLE-ATTACHED BARREL, AND PACKAGE FOR ASSEMBLY FOR SYRINGEMarch 2019May 2022Abandon3820YesNo
16366999DRUG SOLUTION ADMINISTRATION DEVICE AND METHOD FOR CONTROLLING DRUG SOLUTION ADMINISTRATION DEVICEMarch 2019September 2022Allow4230YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DANIEL, ANTARIUS S.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
3
(75.0%)
Examiner Reversed
1
(25.0%)
Reversal Percentile
41.8%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
13
Allowed After Appeal Filing
3
(23.1%)
Not Allowed After Appeal Filing
10
(76.9%)
Filing Benefit Percentile
31.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 23.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner DANIEL, ANTARIUS S - Prosecution Strategy Guide

Executive Summary

Examiner DANIEL, ANTARIUS S works in Art Unit 3783 and has examined 161 patent applications in our dataset. With an allowance rate of 50.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.

Allowance Patterns

Examiner DANIEL, ANTARIUS S's allowance rate of 50.3% places them in the 12% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by DANIEL, ANTARIUS S receive 2.98 office actions before reaching final disposition. This places the examiner in the 86% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DANIEL, ANTARIUS S is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +15.5% benefit to allowance rate for applications examined by DANIEL, ANTARIUS S. This interview benefit is in the 55% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.7% of applications are subsequently allowed. This success rate is in the 12% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 11.6% of cases where such amendments are filed. This entry rate is in the 12% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 114.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 81% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 63.6% of appeals filed. This is in the 43% percentile among all examiners. Of these withdrawals, 71.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 75.0% are granted (fully or in part). This grant rate is in the 81% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.